ECSP088739A - DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME - Google Patents

DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME

Info

Publication number
ECSP088739A
ECSP088739A ECSP088739A ECSP088739A EC SP088739 A ECSP088739 A EC SP088739A EC SP088739 A ECSP088739 A EC SP088739A EC SP088739 A ECSP088739 A EC SP088739A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
ligandos
amidas
derivatives
methods
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Yunfeng Fang
Michael Kelly
Matthew Duncton
Kiran Sahasrabushe
Satynarahana Janagani
Ravindra Upasani
Guoxian Wu
Zhi-Liang Wei
Carl J Kaub
John Kinkaid
Matthew Cox
Original Assignee
Renovis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovis Inc filed Critical Renovis Inc
Publication of ECSP088739A publication Critical patent/ECSP088739A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describen compuestos que tienen una formula representada por la siguiente: Formula ( I). Los compuestos pueden prepararse como composiciones farmacéuticas, y pueden usarse para la prevención y tratamiento de una diversidad de padecimientos en mamíferos incluyendo humanos, incluyendo a manera de ejemplo no limitante, dolor, inflamación, lesión traumática y otros.Compounds having a formula represented by the following are described: Formula (I). The compounds can be prepared as pharmaceutical compositions, and can be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury and others.

ECSP088739 2006-02-23 2008-09-15 DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME ECSP088739A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77610606P 2006-02-23 2006-02-23
US77605806P 2006-02-23 2006-02-23
US77594906P 2006-02-23 2006-02-23
US77605706P 2006-02-23 2006-02-23

Publications (1)

Publication Number Publication Date
ECSP088739A true ECSP088739A (en) 2008-10-31

Family

ID=40459933

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP088739 ECSP088739A (en) 2006-02-23 2008-09-15 DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME

Country Status (1)

Country Link
EC (1) ECSP088739A (en)

Similar Documents

Publication Publication Date Title
ECSP099780A (en) NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
BRPI0709581A8 (en) bicycloetheroyl compounds as px27 modulators and their use
MX379353B (en) SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUND AND ITS USE.
NI200900106A (en) INHIBITORS OF THE ACTIVITY OF THE AKT.
ECSP099792A (en) NEW INHIBITING PEPTIDES FOR HEPATITIS C VIRUS REPLICATION
BRPI0418166A (en) bicycloetheroylamine compounds as ion channel ligands and uses of these
BR112012023021A2 (en) indazole compounds and their uses
CL2013000304A1 (en) Compounds derived from prostaglandin e2 inhibitor 2-arylamino-benzimidazoles (mpges-1); pharmaceutical composition that includes them; intermediary compounds; use in the treatment of inflammatory diseases and / or associated conditions, in particular pain.
CO6341627A2 (en) QUINOXALINE TYPE BRIDGED PIPERIDINE COMPOUNDS REPLACED AND THE USES OF THE SAME
MX384206B (en) DPP IV INHIBITOR FORMULATIONS
DOP2012000150A (en) TRIAZOLOPIRIDINS
CR9580A (en) AKT ACTIVITY INHIBITORS
CU20100203A7 (en) NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
CL2011000504A1 (en) Compounds derived from pyridin-4-yl-thiazol-2-amide 2-amide-pyrrolidin-1,2-dicarboxylic, phosphatidyl-inositol-3 kinase inhibitors; pharmaceutical composition comprising one of the compounds; and use of the compounds in the preparation of a medicament for the treatment of cancer.
EA200970913A1 (en) 2-pyridinecarboxamide derivatives as sodium channel modulators
BRPI0916286B8 (en) amidophenoxy-indazoles useful as c-met inhibitors, their uses, and pharmaceutical composition
BRPI0806863B8 (en) use of a phorbol ester in the preparation of a drug to prevent or treat an HIV infection
BRPI0507198A (en) bisarylurea derivatives
EA201070327A1 (en) CATECHOLAMINE DERIVATIVES AND THEIR DEVICES
ECSP12012338A (en) SUBSTITUTED TRIAZOLOPIRIDINS
EA200801997A1 (en) NEW CONNECTIONS
UY30610A1 (en) MGLUR5 MODULATORS
UY30215A1 (en) CHROMANOL DERIVATIVES REPLACED, PROCEDURES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
NI201100056A (en) MULTIHETEROARYL COMPOUNDS AS INHIBITORS OF PROSTAGLANDIN D HEMATOPOIETIC SYNTHASE AND THEIR USE TO TREAT DISEASES MEDIATED BY PROSTAGLANDIN D2.
GT200600475A (en) PIRAZINE DERIVATIVES